TFP
AMGN icon

Tilia Fiduciary Partners’s Amgen AMGN Stock Holding History

Tilia Fiduciary Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Sell
1,004
-80
-7% -$28.5K 0.19% 90
2025
Q4 		$355K Sell
1,084
-29
-3% -$9.2K 0.2% 90
2025
Q3 		$314K Sell
1,113
-61
-5% -$17.7K 0.18% 95
2025
Q2 		$328K Buy
1,174
+3
+0.3% +$850 0.2% 93
2025
Q1 		$365K Sell
1,171
-75
-6% -$22.1K 0.24% 86
2024
Q4 		$325K Buy
1,246
+2
+0.2% +$593 0.22% 89
2024
Q3 		$401K Buy
1,244
+39
+3% +$12.8K 0.28% 78
2024
Q2 		$376K Sell
1,205
-47
-4% -$13.8K 0.29% 78
2024
Q1 		$356K Buy
1,252
+2
+0.2% +$585 0.29% 79
2023
Q4 		$360K Sell
1,250
-5
-0.4% -$1.36K 0.33% 78
2023
Q3 		$337K Buy
1,255
+103
+9% +$25.7K 0.35% 73
2023
Q2 		$256K Sell
1,152
-28
-2% -$6.5K 0.23% 85
2023
Q1 		$285K Buy
1,180
+3
+0.3% +$736 0.27% 87
2022
Q4 		$309K Buy
1,177
+2
+0.2% +$536 0.3% 85
2022
Q3 		$288K Buy
1,175
+2
+0.2% +$485 0.29% 85
2022
Q2 		$290K Buy
1,173
+105
+10% +$25.7K 0.28% 82
2022
Q1 		$258K Buy
1,068
+2
+0.2% +$460 0.22% 91
2021
Q4 		$240K Buy
+1,066
New +$225K 0.19% 97

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Tilia Fiduciary Partners's AMGN Position: Q1 2026 in Review

Tilia Fiduciary Partners reduced its Amgen (AMGN) stake by 7.4% in Q1 2026, selling an estimated $28.5K and leaving 1,004 shares worth $353K. The position accounts for 0.19% of the portfolio, ranked #90.

Tilia Fiduciary Partners first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $401K in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tilia Fiduciary Partners held 1,004 shares of Amgen worth $353K as of Q1 2026.
  • Tilia Fiduciary Partners sold 80 Amgen shares in Q1 2026, an estimated $28.5K.
  • Amgen made up 0.19% of Tilia Fiduciary Partners's portfolio in Q1 2026, its #90 holding.
  • Tilia Fiduciary Partners first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Tilia Fiduciary Partners's Amgen position peaked at $401K in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tilia Fiduciary Partners's 13F filing for Q1 2026, filed 9 Apr 2026.